These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 23474289)

  • 21. Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Wang Y; Wei X; Xiao X; Hui R; Card JW; Carey MA; Wang DW; Zeldin DC
    J Pharmacol Exp Ther; 2005 Aug; 314(2):522-32. PubMed ID: 15840765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta.
    Cizkova K; Tauber Z
    Acta Histochem; 2018 Aug; 120(6):513-519. PubMed ID: 29908721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.
    Liu PY; Li YH; Chao TH; Wu HL; Lin LJ; Tsai LM; Chen JH
    Atherosclerosis; 2007 Nov; 195(1):199-206. PubMed ID: 17126841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth.
    Chen C; Wei X; Rao X; Wu J; Yang S; Chen F; Ma D; Zhou J; Dackor RT; Zeldin DC; Wang DW
    J Pharmacol Exp Ther; 2011 Feb; 336(2):344-55. PubMed ID: 21030485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs.
    Zhang Y; Gao L; Yao B; Huang S; Zhang Y; Liu J; Liu Z; Wang X
    Life Sci; 2022 Dec; 310():121122. PubMed ID: 36309225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance.
    Zeldin DC; Foley J; Ma J; Boyle JE; Pascual JM; Moomaw CR; Tomer KB; Steenbergen C; Wu S
    Mol Pharmacol; 1996 Nov; 50(5):1111-7. PubMed ID: 8913342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors.
    Jiang JG; Chen CL; Card JW; Yang S; Chen JX; Fu XN; Ning YG; Xiao X; Zeldin DC; Wang DW
    Cancer Res; 2005 Jun; 65(11):4707-15. PubMed ID: 15930289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.
    Xu M; Ju W; Hao H; Wang G; Li P
    Drug Metab Rev; 2013 Aug; 45(3):311-52. PubMed ID: 23865864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arachidonic acid cytochrome P450 epoxygenase pathway.
    Spector AA
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S52-6. PubMed ID: 18952572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium.
    Jia J; Davis CM; Zhang W; Edin ML; Jouihan S; Jia T; Bradbury JA; Graves JP; DeGraff LM; Lee CR; Ronnekleiv O; Wang R; Xu Y; Zeldin DC; Alkayed NJ
    Exp Neurol; 2016 May; 279():75-85. PubMed ID: 26902473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
    Spiecker M; Darius H; Hankeln T; Soufi M; Sattler AM; Schaefer JR; Node K; Börgel J; Mügge A; Lindpaintner K; Huesing A; Maisch B; Zeldin DC; Liao JK
    Circulation; 2004 Oct; 110(15):2132-6. PubMed ID: 15466638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basal and inducible anti-inflammatory epoxygenase activity in endothelial cells.
    Askari AA; Thomson S; Edin ML; Lih FB; Zeldin DC; Bishop-Bailey D
    Biochem Biophys Res Commun; 2014 Apr; 446(2):633-7. PubMed ID: 24631907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
    Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac Disease Alters Myocardial Tissue Levels of Epoxyeicosatrienoic Acids and Key Proteins Involved in Their Biosynthesis and Degradation.
    Aliwarga T; Dinh JC; Heyward S; Prasad B; Gharib SA; Lemaitre RN; Sotoodehnia N; Totah RA
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytochrome p450 epoxygenase promotes human cancer metastasis.
    Jiang JG; Ning YG; Chen C; Ma D; Liu ZJ; Yang S; Zhou J; Xiao X; Zhang XA; Edin ML; Card JW; Wang J; Zeldin DC; Wang DW
    Cancer Res; 2007 Jul; 67(14):6665-74. PubMed ID: 17638876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of cytochrome P450 2C epoxygenases in hypoxia-induced cell migration and angiogenesis in retinal endothelial cells.
    Michaelis UR; Xia N; Barbosa-Sicard E; Falck JR; Fleming I
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1242-7. PubMed ID: 18326754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease.
    Spiecker M; Liao J
    Trends Cardiovasc Med; 2006 Aug; 16(6):204-8. PubMed ID: 16839864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.
    Elmarakby AA
    Am J Physiol Regul Integr Comp Physiol; 2012 Feb; 302(3):R321-30. PubMed ID: 22116511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype.
    Abraham NG; Sodhi K; Silvis AM; Vanella L; Favero G; Rezzani R; Lee C; Zeldin DC; Schwartzman ML
    Hypertension; 2014 Dec; 64(6):1352-61. PubMed ID: 25245389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
    Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
    BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.